Board Disclosures

The leadership of the Journal of Alzheimer's Disease has disclosed the following information in keeping with the journal's disclosure policy.

George Perry, PhD, Editor-in-Chief
Consultant/Advisory Boards: Alzheimer Research and Prevention Foundation, Aria, Neurotez, Takeda
Equity Ownership/Stock Options: Neurotez, Curaxis, Nebulab
Other: IOS Press (strategic advisor), NanoBiotech Pharma (Medical Advisory Committee)

Beth Kumar, Managing Editor
Nothing to Disclose

Jesus Avila, MD, Deputy Editor
Nothing to Disclose

Paula Moreira, PhD, Deputy Editor
Nothing to Disclose

Massimo Tabaton, MD, Deputy Editor
Nothing to Disclose

Xiongwei Zhu, PhD, Deputy Editor
Nothing to Disclose

Allyson Rosen, PhD, ABPP-CN, Ethics Editor
Nothing to Disclose

Aaron A. Sorensen, Scientometrics Editor
Other: IOS Press

Last updated 29 December 2016